Jordan Messer

Jordan Messer is a seasoned professional in the pharmaceutical industry with extensive experience in Global Medical Affairs across several prominent companies. Currently serving as the Global Medical Affairs Lead for the Duchenne Muscular Dystrophy program at Dyne Therapeutics since May 2023, Jordan is recognized as a medical expert in antisense oligonucleotides and leads the development of global medical strategies. Previous roles include Associate Director of Medical Affairs at BioCryst Pharmaceuticals, where Jordan led global scientific communications and stakeholder collaborations, and at Translate Bio, focusing on KOL engagement and clinical study design. Jordan held senior roles during tenure at Biogen and Sanofi Genzyme, managing cross-functional teams and contributing to strategic medical initiatives. A Doctor of Pharmacy graduate from the UNC Eshelman School of Pharmacy, Jordan brings valuable academic and practical insights to the field.